SCHEMBL1506437

SCHEMBL1506437

C[C@@H]1CCCN1C1CC(c2ccc(Br)c(F)c2)C1

nearest known ligand 0.52

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 17/20 0.52
KCNH2 Q12809 3/20 0.52
KDM1A O60341 2/20 0.42
KDM1B Q8NB78 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1506436 1.00 HRH3 (0.52) HRH3KCNH2KDM1AKDM1B
SCHEMBL1506247 0.80 HRH3 (0.63) HRH3KCNH2
SCHEMBL1506346 0.80 HRH3 (0.63) HRH3KCNH2
SCHEMBL1506438 0.80 HRH3 (0.63) HRH3KCNH2
SCHEMBL1506539 0.80 HRH3 (0.63) HRH3KCNH2
SCHEMBL1506345 0.80 HRH3 (0.63) HRH3KCNH2
SCHEMBL1506389 0.80 HRH3 (0.63) HRH3KCNH2
SCHEMBL1506388 0.80 HRH3 (0.63) HRH3KCNH2
SCHEMBL1506246 0.80 HRH3 (0.63) HRH3KCNH2
SCHEMBL1506396 0.77 HRH3 (0.48) HRH3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1888523-B1 CYCLOBUTYL AMINE DERIVATIVES ABBOTT LAB (US) 2011-10-26 EP disclosed
EP-2298734-A2 Cyclobutyl amine derivatives Abbott Laboratories (US) 2011-03-23 EP disclosed
US-20090227593-A1 CYCLOBUTYL AMINE DERIVATIVES ABBOTT LABORATORIES (US) 2009-09-10 US disclosed
US-7553964-B2 Cyclobutyl amine derivatives ABBOTT LABORATORIES (US) 2009-06-30 US disclosed
US-20070078133-A1 Cyclobutyl amine derivatives ABBVIE INC. 2007-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227593-A1 CYCLOBUTYL AMINE DERIVATIVES HRH2, HRH4, HRH3 HRH3 3/4885KCNH2 1616/4885KDM1A 3406/4885
US-20070078133-A1 Cyclobutyl amine derivatives HRH2, HRH4, HRH3 HRH3 3/4885KCNH2 1616/4885KDM1A 3406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.